IDEAYA Biosciences, Inc. Employee Count
The employee counts IDEAYA Biosciences, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 145; Filing 2026-02-17; Lease expense per employee $49,655.17.
- 2024-12-31: Employees (as filed) 131; Filing 2025-02-18; Lease expense per employee $22,900.76.
- 2023-12-31: Employees (as filed) 124; Filing 2024-02-20; Lease expense per employee $25,000.00.
- 2022-12-31: Employees (as filed) 103; Filing 2023-03-07; Lease expense per employee $26,213.59.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 145 | 2026-02-17 | $49,655.17 operating + variable |
| 2024-12-31 | 131 | 2025-02-18 | $22,900.76 operating + variable |
| 2023-12-31 | 124 | 2024-02-20 | $25,000.00 operating + variable |
| 2022-12-31 | 103 | 2023-03-07 | $26,213.59 operating + variable |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |